Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors

Oncology Reports

Volumn 24, Issue 1, 2010, Pages 219-223

  Barillari, Giovanni ^a,b   Franzese, Ornella ^a   Comandini, Alessandro ^a   Bonmassar, Enzo ^a   Ensoli, Barbara ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cell growth; Cell invasion; Cytokines; Human immunodeficiency virus 1 Tat; Kaposi's sarcoma; Telomerase

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; INTERLEUKIN 1BETA; TELOMERASE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; FIBROBLAST GROWTH FACTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANGIOGENESIS; ARTICLE; CASE REPORT; CELL ACTIVATION; CELL INVASION; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; SPINDLE CELL SARCOMA; COMPLICATION; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; SARCOMA, KAPOSI; SKIN NEOPLASMS; TUMOR CELL CULTURE; UPREGULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CYTOKINES; DISEASE PROGRESSION; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; GENE PRODUCTS, TAT; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; MALE; RISK FACTORS; SARCOMA, KAPOSI; SKIN NEOPLASMS; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77952981802     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000849     Document Type: Article

References (28)

1. Blackburn EH: Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 579: 859-862, 2005.
2. Aubert G and Landsdorp PM: Telomeres and aging. Physiol Rev 88: 557-579, 2008.
3. Kaszubowska L: Telomere shortening and ageing of the immune system. J Physiol Pharmacol 59: 169-186, 2008.
4. Krunic D, Moshir S, Greulich-Bode KM, Figueroa R, Cerezo A, Stammer H, Stark HJ, Gray SG, Nielsen KV, Hartschuh W and Boukamp P: Tissue context-activated telomerase in human epidermis correlates with little age-dependent telomere loss. Biochem Biophys Acta 1792: 297-308, 2009.
5. Kurz DJ, Hong Y, Trivier E, Huang HL, Decary S, Zang GH, Luscher TF and Erusalimsky JD: Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscl Thromb Vasc Biol 23: 748-754, 2003. (Pubitemid 36566162)
6. Shay JW and Roninson IB: Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23: 2919-2933, 2004.
7. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Wright WE and Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol. Methods Cell Sci 17: 1-15, 1995.
8. Wisman GB, De Jong S, Meersma GJ, Helder MN, Hollema H, de Vries EG, Keith WN and van der Zee AG: Telomerase in (pre)neoplastic cervical disease. Hum Pathol 31: 1304-1312, 2000.
9. Sharma A, Rajappa M, Saxena A and Sharma M: Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer. Mol Diagn Ther 11: 193-201, 2007. (Pubitemid 46983411)
10. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M and Monini P: Biology of Kaposi's sarcoma. Eur J of Cancer 37: 1251-1269, 2001.
11. Barillari G and Ensoli B: Role of HIV-1 Tat protein in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev 15: 310-326, 2002.
12. Chen Z, Smith KJ, Skelton HG, Barret TL, Greenway HT and Lo SC: Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma. Exp Biol Med 226: 753-757, 2001. (Pubitemid 32785971)
13. Fanales-Belasio E, Moretti S, Fiorelli V, Tripiciano A, Pavone-Cossut MR, Scoglio A, Colacchi B, Nappi F, Macchia I, Bellino S, Francavilla V, Caputo A, Barillari G, Magnani M, Laguardia ME, Cafaro A, Titti F, Monini P, Ensoli F and Ensoli B: HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J Immunol 182: 2888-2897, 2009.
14. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F and Gallo RC: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243: 223-226, 1989. (Pubitemid 19035359)
15. Rocha SF and Adams RH: Molecular differentiation and specialization of vascular beds. Angiogenesis 12: 139-147, 2009.
16. Hume DA: Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol 1: 432-441, 2008.
17. Kaaya EE, Castanos-Velez E, Amir H, Lema L, Luande J, Kitinya J, Patarroy M and Biberfeld P: Expression of adhesion molecules in endemic and epidemic Kaposi's sarcoma. Histopathology 29: 337-346, 1996. (Pubitemid 26338437)
18. Lu ZY, Jensen LE, Huang Y, Kealey C, Blair IA and Whitehead AS: The up-regulation of monocyte chemoattactant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under long-term low folate stress is mediated by the p38 MAPK pathway. Atherosclerosis 205: 48-54, 2009.
19. Barillari G, Sgadari S, Fiorelli V, Samaniego F, Colombini S, Manzari V, Modesti A, Nair BC, Cafaro A, Sturzl M and Ensoli B: The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the α5ß1 and αvß3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 94: 663-672, 1999. (Pubitemid 29323880)
20. Ogawa D, Nomiyama T, Nakamachi T, Heywood EB, Stone JF, Berger JP, Law RE and Bruemmer D: Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells. Circ Res 98: e50-e59, 2006. (Pubitemid 43755233)
21. Zhang DK, Ngan HY, Cheng RY, Cheung AN, Liu SS and Tsao SW: Clinical significance of telomerase activation and telomeric restriction fragment (TFR) in cervical cancer. Eur J Cancer 35: 154-160, 1999.
22. Dorer DE and Nettelbeck DM: Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Adv Drug Deliv Rev 61: 554-571, 2009.
23. Botchkina GI, Kim RH, Botchkina IL, Kirshembaum A, Frisher Z and Adler HL: Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity. Clin Cancer Res 11: 3243-3249, 2005. (Pubitemid 40627871)
24. Onoda N, Ogisawa K, Ishikawa T, Takenaka C, Tahara H, Inaba M, Takashima T and Hirakawa K: Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid. Surg Today 34: 389-393, 2004. (Pubitemid 38626483)
25. Aboulafia DS, Miles SA, Saks SR and Mitsuyasu RT: Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J Acquir Immune Defic Syndr 2: 54-58, 1989. (Pubitemid 19127075)
26. Albrecht H, Stellbrink HJ, Gross G, Berg B, Helmchen V and Mensing H: Treatment of atypical leishmaniosis with interferon-gamma resulting in progression of Kaposi's sarcoma in an AIDS patients. Clin Invest 72: 1041-1047, 1994.
27. Shariftabrizi A, Khorramizadeh MR, Saadat F, Alimoghadam K, Safavifar F and Ebrahimkhani MR: Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells. Mol Cell Biochem 273: 109-116, 2005. (Pubitemid 40766791)
28. Savage CO: Vascular biology and vasculitis. APMIS (Suppl) 127: 37-40, 2009.